FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034334866> ?p ?o ?g. }

• W2034334866 endingPage "40" @default.
• W2034334866 startingPage "31" @default.
• W2034334866 abstract "FK506 has been proven effective for prevention and treatment of liver allograft rejection. Herein, we compare FK506-based immunosuppression with an effective quadruple immunosuppressive regimen, including cyclosporine and antithymocyte globulin. The results of a single center participating in the European multicenter FK506 study are reported, including immunosuppressive efficacy as well as toxicity. Oneyear patient and graft survival was 96.7% and 90.0% for the CsA group and 90.2% and 88.5% for the FK506 group, which is not statistically different. The incidence and severity of acute rejection episodes during the first postoperative year was similar in both treatment groups with 34.4% and 33.3% for the FK506 and CsA treatment group, respectively. Immunosuppressive potency was better for the FK506 group compared with the CsA group according to the incidence of chronic rejection. Furthermore, 5 patients (8.3%) required conversion to FK506 for immunological reasons, i.e., refractory acute or chronic rejection. The incidence of moderate and severe neurotoxicity during the early postoperative period was higher in the FK506 group (21.3%) compared with the CsA group (11.7%), while the incidence of renal insufficiency and acute renal failure was similar (18.0% and 18.3% for the FK506 and CsA treatment groups, respectively). The incidence of CMV infection was significantly higher under treatment with CsA (25.0%) than with FK506 (6.6%) (P≤0.05), while the incidence of pneumonia (13.1% and 13.3%), cholangitis (29.5% and 26.7%), and urinary tract infection (39.3% and 28.3% for the FK506 and CsA treatment groups, respectively) was similar in both treatment groups. However, infection was more serious in some cases treated with FK506, and evolved as the main cause of death in the FK506 treatment group. Therefore, caution should be paid to overimmunosuppression and toxicity in FK506-treated patients. Regarding the monitoring of FK506, FK506 plasma level failed to be a reliable indicator, and therefore we recommend measurement of whole blood FK506 levels. Our data indicate that immunosuppressive potency of FK506 is greater than that of CsA, especially concerning the incidence of chronic rejection." @default.
• W2034334866 created "2016-06-24" @default.
• W2034334866 creator A5014561526 @default.
• W2034334866 creator A5025136303 @default.
• W2034334866 creator A5027961989 @default.
• W2034334866 creator A5029875871 @default.
• W2034334866 creator A5030045751 @default.
• W2034334866 creator A5035782273 @default.
• W2034334866 creator A5039955667 @default.
• W2034334866 creator A5040837927 @default.
• W2034334866 creator A5040922655 @default.
• W2034334866 creator A5049713502 @default.
• W2034334866 creator A5049888016 @default.
• W2034334866 creator A5054738007 @default.
• W2034334866 creator A5060059550 @default.
• W2034334866 creator A5065444044 @default.
• W2034334866 creator A5068991157 @default.
• W2034334866 creator A5072067137 @default.
• W2034334866 creator A5088620866 @default.
• W2034334866 date "1995-01-01" @default.
• W2034334866 modified "2023-10-06" @default.
• W2034334866 title "COMPARISON OF FK506- AND CYCLOSPORINE-BASED IMMUNOSUPPRESSION IN PRIMARY ORTHOTOPIC LIVER TRANSPLANTATION" @default.
• W2034334866 doi "https://doi.org/10.1097/00007890-199501150-00007" @default.
• W2034334866 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7530868" @default.
• W2034334866 hasPublicationYear "1995" @default.
• W2034334866 type Work @default.
• W2034334866 sameAs 2034334866 @default.
• W2034334866 citedByCount "111" @default.
• W2034334866 countsByYear W20343348662014 @default.
• W2034334866 countsByYear W20343348662015 @default.
• W2034334866 countsByYear W20343348662020 @default.
• W2034334866 countsByYear W20343348662022 @default.
• W2034334866 crossrefType "journal-article" @default.
• W2034334866 hasAuthorship W2034334866A5014561526 @default.
• W2034334866 hasAuthorship W2034334866A5025136303 @default.
• W2034334866 hasAuthorship W2034334866A5027961989 @default.
• W2034334866 hasAuthorship W2034334866A5029875871 @default.
• W2034334866 hasAuthorship W2034334866A5030045751 @default.
• W2034334866 hasAuthorship W2034334866A5035782273 @default.
• W2034334866 hasAuthorship W2034334866A5039955667 @default.
• W2034334866 hasAuthorship W2034334866A5040837927 @default.
• W2034334866 hasAuthorship W2034334866A5040922655 @default.
• W2034334866 hasAuthorship W2034334866A5049713502 @default.
• W2034334866 hasAuthorship W2034334866A5049888016 @default.
• W2034334866 hasAuthorship W2034334866A5054738007 @default.
• W2034334866 hasAuthorship W2034334866A5060059550 @default.
• W2034334866 hasAuthorship W2034334866A5065444044 @default.
• W2034334866 hasAuthorship W2034334866A5068991157 @default.
• W2034334866 hasAuthorship W2034334866A5072067137 @default.
• W2034334866 hasAuthorship W2034334866A5088620866 @default.
• W2034334866 hasBestOaLocation W20343348661 @default.
• W2034334866 hasConcept C120665830 @default.
• W2034334866 hasConcept C121332964 @default.
• W2034334866 hasConcept C126322002 @default.
• W2034334866 hasConcept C141071460 @default.
• W2034334866 hasConcept C2779609443 @default.
• W2034334866 hasConcept C2780252810 @default.
• W2034334866 hasConcept C2781413609 @default.
• W2034334866 hasConcept C2909675724 @default.
• W2034334866 hasConcept C2911091166 @default.
• W2034334866 hasConcept C61511704 @default.
• W2034334866 hasConcept C71924100 @default.
• W2034334866 hasConcept C77411442 @default.
• W2034334866 hasConcept C90924648 @default.
• W2034334866 hasConceptScore W2034334866C120665830 @default.
• W2034334866 hasConceptScore W2034334866C121332964 @default.
• W2034334866 hasConceptScore W2034334866C126322002 @default.
• W2034334866 hasConceptScore W2034334866C141071460 @default.
• W2034334866 hasConceptScore W2034334866C2779609443 @default.
• W2034334866 hasConceptScore W2034334866C2780252810 @default.
• W2034334866 hasConceptScore W2034334866C2781413609 @default.
• W2034334866 hasConceptScore W2034334866C2909675724 @default.
• W2034334866 hasConceptScore W2034334866C2911091166 @default.
• W2034334866 hasConceptScore W2034334866C61511704 @default.
• W2034334866 hasConceptScore W2034334866C71924100 @default.
• W2034334866 hasConceptScore W2034334866C77411442 @default.
• W2034334866 hasConceptScore W2034334866C90924648 @default.
• W2034334866 hasIssue "1" @default.
• W2034334866 hasLocation W20343348661 @default.
• W2034334866 hasLocation W20343348662 @default.
• W2034334866 hasLocation W20343348663 @default.
• W2034334866 hasOpenAccess W2034334866 @default.
• W2034334866 hasPrimaryLocation W20343348661 @default.
• W2034334866 hasRelatedWork W1705018154 @default.
• W2034334866 hasRelatedWork W2003755555 @default.
• W2034334866 hasRelatedWork W2039925961 @default.
• W2034334866 hasRelatedWork W2056167279 @default.
• W2034334866 hasRelatedWork W2059625510 @default.
• W2034334866 hasRelatedWork W2333478547 @default.
• W2034334866 hasRelatedWork W2413053858 @default.
• W2034334866 hasRelatedWork W2885145842 @default.
• W2034334866 hasRelatedWork W3134128215 @default.
• W2034334866 hasRelatedWork W4254171834 @default.
• W2034334866 hasVolume "59" @default.
• W2034334866 isParatext "false" @default.
• W2034334866 isRetracted "false" @default.
• W2034334866 magId "2034334866" @default.
• W2034334866 workType "article" @default.